263
Views
129
CrossRef citations to date
0
Altmetric
Review

The potential adverse effects of habitual use of Catha edulis (khat)

Pages 1145-1154 | Published online: 28 Oct 2005

Bibliography

  • KALIX P, BRANDEN O: Pharmacological aspects of the chewing of khat leaves. Pharmacol Rev (1985) 37:149–164.
  • BRENNEISEN R, FISCH HU, KOELBING U, GEISSHUSLER S, KALIX P: Amphetamine-like effects in humans of the khat alkaloid cathinone. Br. J. Chi]. Pharinacol (1990) 30:825–828.
  • CARLINI EA: Plants and the central nervous system. Pharinacol Biochein. Behav. (2003) 75:501–512.
  • KALIX P: The pharmacology of khat. Gen. Pharinacol (1984) 15:179–187.
  • KENNEDY JG, TEAGUE J, FAIRBANKS L: Qat use in North Yemen and the problem of addiction: a study in medical anthropology. Cult. Med. Psychiatry (1980) 4:311–344.
  • PANTELIS C, HINDLER CG, TAYLOR JC: Use and abuse of khat (Catha edulis): a review of the distribution, pharmacology, side effects and a description of psychosis attributed to khat chewing. Psycho] Med. (1989) 19:657–668.
  • DATE J, TANIDA N, HOBARA T: Qat chewing and pesticides: a study of adverse health effects in people of the mountainous areas of Yemen. Int. I Environin. Health Res. (2004) 14:405–414.
  • SELASSIE SG, GEBRE A: Rapid assessment of drug abuse in Ethiopia. Narc. (1996) 48:53–63.
  • KEBEDE Y: Cigarette smoking and khat chewing among university instructors in Ethiopia. East Afr. Med. J. (2002) 79:274–278.
  • AYANA AM, SHERIEF HT, TEKLI Y: Effect of khat (Catha edulisForsk) on blood pressure and heart rate, a community based study. Ethiop. J. Health Dev. (2002) 16:325–334.
  • ELIM AS: The chewing of khat in Somalia. Ethnopharinacol (1983) 8:163–176.
  • ODENWALD M, NEUNER F, SCHAUER M et al: Khat use as risk factor for psychotic disorders: a cross-sectional and case-control study in Somalia. BMC Medicine (2005) 3:5–12.
  • UNODC: World Drug Report 2004. United Nations Office on Drugs and Crime, Vienna, Austria (2004).
  • GRIFFITHS P: Qat use in London: a study of Qat use among a sample of Somalis living in London. Home Office Drugs Prevention Initiative, Home Office, London, UK (1998).
  • ROUSSEAU C, SAID TM, GAGNE MJ, BIBEAU G: Between myth and madness: the premigration dream of leaving among young Somali refugee. Cult. Med. Psychiatry (1998) 22:385–411.
  • AHMED AG, SALIB E: The khat users: a study of khat chewing in Liverpool's Somali men. Med. ScL Law (1998) 38:165–169.
  • KITE GC, ISMAIL M, SIMMONDS M, HOUGHTON P: Use of doubly protonated molecules in the analysis of cathedulins in crude extracts of lhat (Catha edulis) by liquid chromatography/ serial mass spectrometry. Rapid Communic. Mass Spectrom. (2003) 17:1553–1564.
  • SZENDREI K: The chemistry of khat. Narc. (1980) 32:5–35.
  • KALIX P: Cathinone, a natural amphetamine. Pharmacol Toxicol (1992) 70:77–86.
  • SCHORNO X, STEINEGGER E: CNS-active phenylpropylamines of Catha edulisForsk (Celastraceae) of Kenyan origin. Experintia (1979) 35:572–574.
  • BRENNEISEN R, GEISSHUSLER S: Psychotropic drugs. Part III. Analytical and chemical aspects of Catha edulisForsk. Pharm. Acta Helv. (1985) 60:290–301.
  • SCHECHTER MD: Dopaminergic nature of acute cathine tolerance. Pharmacol Biochem. Behav. (1990) 36:817–820.
  • BRENNEISEN R, GEISSHUSLER S, SCHORNO X: Merucathine, a new phenylalkylamine from Catha edulis. Planta Med. (1984) 50:531.
  • BRENNEISEN R, GEISSHUSLER S: Phenylpentenylamines from Catha edulis. J. Nat. Prod. (1987) 50:1188–1189.
  • SAMUELSSON G: Drugs of Natujl Origin, A Textbook of Pharmacognosy. Swedish Pharmaceutical Press, Stockholm, Sweden (1992).
  • RAMAN R: Catha edulisForsk, geographical dispersal, botanical, ecological and agronomical aspects with special references to Yemen Arab Republic. PhD. Thesis, University of Gottingen, Germany (1983).
  • LUGMAN W, DANOWSKI T: The use of khat in Yemen: social and medical observations. Ann. Intern. Med. (1976) 85:245–249.
  • SPARAGO M, WIOS J, YUAN J et al.: Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse. Pharmacol Exp. Then (1996) 279:1943–1952.
  • ZELGER JL, SCHORNO HX, CARLINI EA: Behavioural effects of cathinone, an amine obtained from Catha edulis Forsk: comparisons with amphetamine, norpseudoephedrine, apomorphine and nomifensine. Bull. Narc. (1980) 32:67–81.
  • MEREU GP, PACITTI C, ARGIOLAS A: Effect of (-)-cathinone, a khat leaf constituent on dopaminergic firing and dopamine metabolism in the rat brain. Life Sci. (1982) 32:1383–1389.
  • GOUDI AJ, ATKINSON J, WEST CR: Discriminative properties of the psychostimulant DL-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation. Neuropharmacology (1986) 25:85–94.
  • CONNOR J, MAKONNEN E, ROSTOM A: Comparison of analgesic effects of khat (Catha edulis Forsk) extract D-amphetamine and ibuprofen in mice. Pharm. Pharmacol (2002) 52:1–6.
  • NENCINI P, AHMED AM: Khat consumption: a pharmacological review. Drug Alcohol Depend. (1989) 23:19–29.
  • KALIX P: Pharmacological properties of the stimulant khat. Pharmacol Then (1990) 48:397–416.
  • WOOLVERTON WL, JOHANSON CE: Preference in rhesus monkeys given a choice between cocaine and d,l-cathinone. J. Exp. Anal. Behav. (1984) 41:35–43.
  • BRENNEISEN R, GEISSHUSLER S, SCHORNO X: Metabolism of cathinone to (-)-norephedrine and (-)-norpseudoephedrine. I Pharm. Pharmacol (1986) 38:298–300.
  • MORAD AM, AL-MESHAL IA, NASIR M, EL-FERALY FS: High-performane liquid chromatographic determinati on of (-)-cathinone in plasma. Chromatographia (1989) 27:201–204.
  • BRENNEISEN R, MATHYS K, GEISSHUSLER S, FISCH H-U, KOELBING U, KALIX P: Determination of S-0-cathinone and its main metabolite R,S-0-norephedrine in human plasma by high-performance liquid chromatography and photodiode array detection. J. Lig. Chromatog. (1991) 14:271–286.
  • WIDLER P, MATHYS K, BRENNEISEN R, KALIX P, FISCH HU: Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clia Pharinacol Ther. (1994) 55:556–562.
  • HALKET JM, KARASU Z, MURRAY-LYON IM: Plasma cathinone levels following chewing khat leaves (Catha edulis Forsk). Ethnopharmacol (1995) 49:111–113.
  • TOENNES SW, KAUERT GF: Study on the excretion and detection of cathinone, cathine and phenylpropanolamine in urine after khat chewing. Clin. Chem. (2002) 48:1715–1719.
  • •Detection of Catha adults alkaloid fractions and their metabolites in blood.
  • TOENNES SW, HARDER S, SCHRAMM M, NIESS C, KAUERT GF: Absorption, distribution and elimination of cathinone, cathine and norephedrine after chewing of khat leaves. BE J. Clia Pharmacol (2003) 56:125–130.
  • •Absorption and pharmicokinetics of the Catha adults alkaloids cathinone, cathine and norephedrine.
  • TOENNES SW, KAUERT GF: Driving under the influence of khat-alkaloid concentrations and observations in forensic cases. Forensic Sci. Int. (2004) 140:85–90.
  • MATHYS K, BRENNEISEN R: Determination of (s)-(-)-cathinone and its metabolites (R,S)-0-norephedrine and (R,M-0-norpseudoephdrine in urine by high-performance liquid chromatography with photodiode-array detection. Chromatog. (1992) 593:79–85.
  • KALIX P: Khat, an amphetamine-like stimulant. J. Psychoactive Drugs (1994) 26:69–74.
  • ROTHMAN RB, NGA V, PARTILLA JS et al: In-vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions and norepinephrine transporter substrates. .J. Pharmacol Exp. Therapy (2003) 307:138–145.
  • •Involvement of (-)-adrenergic receptors with cathinone and amphetamine.
  • TARIQ M, PARMAR NS, QURESHI S et al.: Clastogenic evaluation of cathinone and amphetamine in somatic cells of mice. Mutat Res. (1987) 190:153–157.
  • CLEARY L, BUBER R, DOCHERTY JR: Effects of amphetamine derivatives and cathinone on noradrenaline-evoked contractions of rat right ventricle. Eur. Pharmacol (2002) 451:303–308.
  • CLEARY L, DOCHERTY JR: Actions of amphetamine derivatives and cathinone at the noradrenaline transporter. Eur. Pharmacol (2003) 476:31–34.
  • HALBACH H: Medical aspects of chewing khat leaves. WHO. Bull. (1972) 47:21–29.
  • KALIX P: Khat: a plant with amphetamine effect. J. Subst. Abuse Treat. (1988) 5:163–169.
  • ALEM A, SHIBRE T: Khat induced psychosis and its medico-legal implication: a case report. Ethiop. Med. J. (1997) 35:137–139.
  • AWAS M, KEBEDE D, ALEM A: Major mental disorders in Butajira, southern Ethiopia. Acta. Psychiatry Scand. Suppl. (1999) 397:56–64.
  • JAGER AD, SIRELING L: Natural history of khat psychosis. Aust. N Z I Psychiatry (1994) 28:331–332.
  • YOUSEF G, HUQ Z, LAMBERT T: Khat chewing as a cause of psychosis. Br. J. Hasp. Med. (1995) 54:322–326.
  • DHADPHALE M, OMOLO OE: Psychiatric morbidity among khat chewers. East Aft: Med. J. (1988) 65:355–359.
  • GRIFFITHS P, GOSSOP M, WICKENDEN S, DUNWORTH J, HARRIS K, LLOYD C: A transcultural pattern of drug use: qat (khat) in the UK. Br. J. Psychiatry (1997) 170:281–284.
  • BHUI K, ABID A, ABDI M et al: Traumatic events, migration characteristics and psychiatric symptoms among Somali refugees - Preliminary communication. Soc. Psychiatry Psychiam Epidemiol (2003) 38:35–43.
  • POOLE R, BARABBINS C: Drug induced psychosis. Br. j. Psychiatry (1996) 168:135–138.
  • PHILLIPS P, JOHNSON S: How does drug and alcohol misuse develop among people with psychotic illness? A literature review. Soc. Psychiatry Psychiatr. Epidemiol (2001) 36:269–276.
  • GRIFFITH JD, CAVANAUGH J, HELD J, OATES JA: Dextroamphetamine. Evaluation of psychomimetic properties in man. Arch. Gen. Psychiatry (1972) 26:97–100.
  • BELL DS: The experimental reproduction of amphetamine psychosis. Arch. Gen. Psychiatry (1973) 29:35–40.
  • ROBINSON TE, BECKER JB: Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Bran Res. (1986) 396:157–198.
  • JANOWSKY DS, DAVIS JM: Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. Arch. Gen. Psychiatry (1976) 33:304–308.
  • ANGRIST B, ROTROSEN J, GERSHON S: Differential effects of amphetamine and neuroleptics on negative versus positive symptoms in schizophrenia. Psychopharmacology (Berl) (1980) 72:17–19.
  • HASSAN NA, GUNAID AA, EL-KHALLY FM, MURRAY-LYON IM: The effect of chewing Khat leaves on human mood. Saudi Med. 1 (2002) 23(7):850–853.
  • CONNOR JD, ROSTOM A, MAKONNEN E: Comparison of effects of khat extract and amphetamine on motor behaviors in mice. J. Ethnopharmacol (2002) 81(1):65–71.
  • BANJAW MY, SCHMIDT WJ: Behavioural sensitization following repeated intermittent oral administration of Catha edulis in rats. Behav. Brain Res. (2005) 156:181–189.
  • •The capacity of repeated oral administration of Catha adults in eliciting a long-lasting behavioural sensitisation In rats.
  • BANJAW MY, FENDT M, SCHMIDT WJ: Clozapine attenuates the locomotor sensitization and the prepulse inhibition deficit induced by a repeated oral administration of Catha edulis extract and cathinone in rats. Behav. Brain Res. (2005) 160:365–373.
  • •Intermittent oral administration of cathinone or Catha adults extracts affecting animal behavioural model psychosis via Induction of locomotor sensitisation and perpulse inhibition deficit in rats.
  • LI Z, ICHIKAWA J, MELTZER HY: A comparison of the effect of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens. Psychopharmacology (2003) 167:315–323.
  • ARSENEAULT L, CANNON M, WITTON J, MURRAY RM: Causal association between cannabis and psychosis examination of the evidence. Br. J. Psychiatry (2004) 184:110–117.
  • MAITAI CK, DHADPHALE M: Khat-induced paranoid psychosis. Br. J. Psychiatry (1988) 152:294.
  • NUMAN N: Exploration of adverse psychological symptoms in Yemeni khat users by the symptoms checklist-90 (SCL-90). Addiction (2004) 99:61–65.
  • GALKIN VA, MIRONYCHEV AV, KORSAKOVA SS: Effect of the narcotic khat (catha edulis) on certain functions of the human body. Z Nevropat. Psikh. Imeni. (1962) 62:1396–1397.
  • MUESER KT, DRAKE RE, WALLACH MA: Dual diagnosis: a review of etiological theories. Addict. Behav. (1998) 23:717–734.
  • NIELEN RJ, VAN DER HEIJDEN FM, TUINIER S, VERHOEVEN WM: Khat and mushrooms associated with psychosis. World J. Biol. Psychiatry (2004) 5(1):49–53.
  • NENCINI P, AHMED AM: Naloxone reversible antinociceptive activity of cathinone, the active principal of khat, in the mouse and rat. Pharmacol Res. Commun. (1982) 14:759–770.
  • TRENTIN AP, SANTOS ARS, MIGUEL OG, PIZZOLATTI MG, YANES RA, CALIXTO JB: Mechanisms involved in the antinociceptive effect in mice of the hydroalcoholic extract of Siphocampylus verticillatus. j Pharm. Pharmacol (1997) 49:567–572.
  • NENCINI P, ABDLLAH A, AMICONI G, ELMI A: Tolerance develops to sympathetic effects of khat in humans. Pharmacology (1984) 28:150–154.
  • HASSAN NA, GUNAID AA, ABDO RABBO AA ET AL: The effect of khat chewing on blood pressure and heart rate in healthy volunteers. Trop. Doct. (2000) 30:107–108.
  • KOHLI J, GOLDBERG L: Cardiovascular effect of (-)-cathinone in the anaesthetized dog: Comparison with (+amphetamine. Pharm. Pharmacol (1982) 34:338–340.
  • KALIX P: Effect of the alkaloid cathinone on the release of radioactivity from rabbit atria prelabelled with 3H-norepinepherine. Life Sci. (1983) 32:801–807.
  • AL-MOTARREB A, BAKER K, BROADLEY KJ: Khat: Pharmacological and medical aspects and its social use in Yemen. Phytotherapy Res. (2002) 16:403–413.
  • •A review covering several aspects of Catha edulis including: history, cultivation and social aspects of Catha edulis chewing In Yemen.
  • AL-MOTARREB AL, BROADLEY KJ: Coronary and aortic vasoconstriction by cathinone, the active constituent of khat. Auton, Autacoid Pharmacol (2003) 23(5-6):319–326.
  • AL-MOTARREB A, BRIANCON S, AL-JABER N et al.: Khat chewing is a risk factor for acute myocardial infarction: a case-control study. Br.Pharmacol(2005) 59:574–581.
  • WHO ADVISORY GROUP: Review of the Pharmacology of khat. Bull. Narcotics (1980) 32:83–93.
  • HEYMANN TD, BHUPULAN A, ZUREIKAT NE, DRINKWATER C, GILES P, MURRAY LYON IM: Khat chewing delays gastric emptying of a semi-solid meal. Aliment. Pharmacol Ther. (1995) 9:81–83.
  • GUNAID AA, EL-KHALLY FM, HASSAN NA, MURRAY LYON IM: Chewing qat leaves slows the whole gut transit time. Saudi Med. J. (1999) 20:444–447.
  • MAKONNEN E: Constipating and spasmolytic effects of khat (Catha edulis Forsk) in experimental animals. Phytomedicine (2000) 74:309–312.
  • NASHER AA, QIRBI AA, GHAFOOR MA et al: Khat chewing and bladder neck dysfunction. A randomized control trial of a-adrenergic blockade. BE J. Dia (1995) 75:597–598.
  • AL-HABORI M, AL-MAMARY M: Long-term feeding effects of Catha edulis leaves on blood constituents in animals. Phytomedicine (2004) 11:639–644.
  • SAIF-ALI R, AL-QIRRBI A, AL-GEIRY A, AL-HABORI M: Effect of Catha edulis on glucose and C-peptide in both Type 2 diabetics and non-diabetics. Ethnopharmacol (2003) 86:45–49.
  • •A human study showing Catha edulis to increase plasma glucose and C-peptide levels in diabetic Catha edulis chewers contrary to the general belief.
  • LI JH, LIN LF: Genetic toxicology of abused drugs: a brief review. Mutagenesis (1998) 13:557–565.
  • KASSIE F, DARROUDI F, KUNDI M, SCHNLTE-HERMANN, R, KNASMULLER S: Khat (Catha edulis) consumption causes genotoxic effects in humans. Int. J. Cancer (2001) 92:329–332.
  • •Genotoxic effect of Catha edulis use through the formation of micronuclei in human buccal and bladder mucosa.
  • DRAKE P: Khat chewing in the near east.Lancet (1988) 8584:532–533.
  • GUNAID AA, SUMAIRI AA, SHIDRAWI RG et al: Oesophageal and gastric carcinoma in the republic of Yemen. Br. J. Cancer (1995) 71:409–410.
  • AL-MAMARY M, AL-HABORI M: Nitrosamine formation from different Catha edulis leaves extracts under simulated gastric condition. Food Chem. (2005) In press.
  • •In vitro formation of nitrosamines from Catha edulis under simulated gastric conditions and its possible involvement in the observed higher incidence of oesophageal and forestomach carcinomas in Yemen.
  • SOUFI HE, KAMESWARAN M, MALATANI T: Khat and oral cancer. Laryngol OM] (1991) 105:643–645.
  • NASR AH, KHATRI ML: Head and necksquamous cell carcinoma in Hajjah, Yemen. Saudi Med. J. (2000) 21:565–568.
  • Hill CM, GIBSON A: The oral and dental effects of q'at chewing. Ora] Surg. Oral Med. Ora] Pathol (1987) 63:433–436.
  • SANKARANARAYANAN R: Oral cancer in India: an epidemiologic and clinical review. Ora] Surg. Ora] Med. Ora] Pathol (1990) 69:325–330.
  • SANKARANARAYANAN R, DUFFY SW, PADMAKUMARY G et al: Risk factors for cancer of the buccal and labial mucosa in Kerala, Southern India. J. Epidemiol Community Health (1990) 44:286–292.
  • ALI AA, AL-SHARABI AK, AGUIRRE JM, NAHAS R: A study of 342 oral keratotic white lesions induced by qat chewing among 2500 Yemeni.' Oral Pathol Med. (2004) 33(6):368–372.
  • MARKER P, KROGDAHL A: Plasma cell gingivitis apparently related to the use of khat: report of a case. Br. Dent. J. (2002) 192(6):311–313.
  • •A histological examinations relating Catha edulis use with plasma cell gingivitis.
  • AL-HEBSHI NN, SKAUG N: Effect of khat chewing on 14 selected periodontal bacteria in sub- and supragingival plaque of a young male population. Oral Microbiol. Immunol (2005) 20(3):141–146.
  • AL-QIRIM TM, SHAHWAN M, ZAIDI KR, UDDIN Q, BANU N: Effect of khat, its constituents and restraint stress on free radical metabolism of rats. Ethnopharmacol. (2002) 83:245–250.
  • •Catha adults alkaloids consumption preceding stress affecting free radical metabolising/scavenging enzymes; whereas the Catha adults flavonoids fraction possess antioxidant properties.
  • AL-ZUBAIRI A, AL-HABORI M, AL-GEIRY A: Effect of Catha edulis (khat) chewing on plasma lipid peroxidation. Ethnopharmacol. (2003) 87:3–9.
  • •A human study highlighting the lack of effect of Catha adult's on lipid peroxidation via measurements of malondialdehyde, and possible antioxidant property.
  • HAGERMAN AE, RIEDL KM, JONES GA et al: High molecular weight plant polyphenolics (Tannins) as biological antioxidants. I Agile& Food Chem. (1998) 46:1887–1892.
  • KOGA T, MORO K, YAMAKOSHI J, HOSOYAMA H, KATAOKA S, ARIGA T: Increase of antioxidative potential of rat plasma by oral administration of proanthocynidin-rich extract from grape seeds. Agricul. Food Chem. (1999) 47:1892–1897.
  • AL-AHDAL MN, MCGARRY TJ, HANNAN M: Cytoxicity of khat (Catha edulis) extract on cultured mammalian cells: effects on macromolecule biosynthesis. Mutation Res. (1988) 204:317–322.
  • AL-MESHAL I, QURESHI S, AGEEL AM, TARIQ M: The toxicity of Catha edulis in mice. I Subst. Abuse (1991) 3:107–115.
  • AL-MAMARY M, AL-HABORI M, AL-AGHBARI AM, BAKER MM: Investigation into the toxicological effects of Catha edulis leaves: A short term study in animals. Phytotherapy Res. (2002) 16:127–132.
  • •A histopathological and biochemical study of the cytotoxic effects of Catha adults consumption in an animal model.
  • AL-HABORI M, AL-AGHBARI AM, AL-MAMARY M, BAKER M: Toxicological evaluation of Catha edulis leaves: A long term feeding experiment in animals. Ethnopharmacol (2002) 83:209–217.
  • DIMBA E, GJERTSEN BT, FRANCIS GW, JOHANNESSEN AC, VINTERMYR OK: Catha edulis (khat) induces cell death by apoptosis in leukemia in cell lines. Ann. NY Acad. Sci. (2003) 1010:384–388.
  • DIMBA E, GJERTSEN BT, BREDHOLT T et al: Khat (Catha edulis) -induced apoptosis is inhibited by antagonists of caspase-1 and -8 in human leukemia in cells. Br. I Cancer (2004) 91:1726–1734.
  • •Catha adults induction of a selective type of cell death having all morphological and biochemical features of apoptotic cell death.
  • KERR JFR, WYLLIE AH, CURRIE AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer (1972) 26:239–257.
  • WYLLIE AH, KERR JFR, CURRIE AR: Cell death: the significance of apoptosis. Int. Rev Cytol. (1980) 68:251–305.
  • JENSEN PH, FLADMARK KE, GJERTSEN BT, VINTERMYER OK: Caspase-1 related protease inhibition retards the execution of okadaic acid- and camptothecin-induced apoptosis and PAI-2 cleavage, but not commitment to cell death in HL-60 cells. BE J. Cancer (1999) 79:1685–1691.
  • TAHA SA, AGEEL AM, ISLAM MW, GINAWI OT: Rffect of (-)-cathinone, a psychoactive alkaloid from khat (Catha eduliset Forsk) and caffeine on sexual behaviour in rats. Pharmacol Res. (1995) 31:299–303.
  • QUERESHI S, TARIQ M, EL-FERALY FS, AL-MESHAL IA: Genetic defects of chronic treatment with cathinone in mice. Mutagenesis (1998) 3:481–483.
  • ISLAM MW, TARIQ M, AGEEL AM, EL-FERALY FS, AL-MESHAL IA: An evaluation of the male reproductive toxicity of cathinone. Toxicology (1990) 60:223–234.
  • EL-SHOURA SM, ABDEL AZIZ M, ALI ME et al: Deleterious effects of khat addiction on semen parameters and sperm ultrastructure. Human Reprod. (1995) 10:2295–2300.
  • HAKIM LY: Influence of khat on seminal fluid among presumed infertile couples. East Afr. Med. J. (2002) 79(1):22–28.
  • ADEOYA-OSIGUWA SA, FRASER LR: Cathine and norephedrine, both phenylpropanolamines, accelerate capacitation and then inhibit spontaneous acrosome loss. Human Reprod. (2005) 20:198–207.
  • •Catha adults phenylpropanolamines (cathine and norephedrine) effect on mammalian sperm function, accelerating capacitation and possible enhancement of natural fertility. Affiliation

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.